Footnotes Relating To: The IP Year 2008 In Review: Patents (Part 1 of 3)

The IP Year 2008 In Review: Patents (Part

1)

The IP Year 2008 In Review: Trademarks (Part

2)

The IP Year 2008 In Review: Copyrights (Part

3)

Footnotes

1 MONDAQ (http://www.mondaq.com/) awarded Fasken

Martineau's The IP Year 2007 In Review the most

popular Canadian article on its site in February, 2008. See http://www.mondaq.com/content/awards.asp?id=0539E265-6379-41AB-B278-66CBB5FF3769.

2 http://laws.justice.gc.ca/en/P-4/SOR-96-423/index.html

3 http://www.cipo.ic.gc.ca/epic/site/cipointernet-internetopic.nsf/en/h_wr00030e.html#nov27

4 Patented Medicines (Notice of Compliance)

Regulations (http://laws.justice.gc.ca/en/showtdm/cr/SOR-93-133)

5 http://www.cipo.ic.gc.ca/epic/site/cipointernet-internetopic.nsf/en/h_wr00030e.html#sept29

6 http://www.wipo.int/pct-safe/en/

7 http://www.wipo.int/pct-safe/en/certificates.htm

8 https://strategis.ic.gc.ca/cgi-bin/allsites/registration/mainScreen.cgi

9http://www.wipo.int/pct/guide/en/gdvol1/annexes/annexc/ax_c_ca.pdf

10 http://www.cipo.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/wr01221.html.

For a more detailed review, please see the Fasken Martineau

practice notice at http://www.fasken.com/Publications/Detail.aspx?publication=4347.

11 http://www.aipla.org/Content/ContentGroups/About_AIPLA1/AIPLA_Reports/20084/bilski.pdf

. For a more detailed review, please see the Fasken Martineau

practice notice at http://www.fasken.com/ip_bulletin_nov2008/

12 See The IP Year 2007 in Review http://www.fasken.com/ip_the_year_2007_in_review/

. Briefly, the New Rules issued by the USPTO on August 1st 2007

were crafted to significantly limit the number of continuation

applications, continuation-in-part applications and requests for

continued examination (RCEs) that could be filed by an applicant.

The New Rules were also designed to strongly discourage applicants

from filing more than five independent claims or more than 25 total

claims.

13 2008 FC 712.

14 2008 FCA 35.

15 See IP Year 2006 in Review http://www.fasken.com/publications/detail.aspx?publication=2694

.

16 2008 FC 608

17 Pfizer Canada Inc. v. Canada (Health), 2008 FCA 108; Glaxosmithkline Inc. v.

Pharmascience Inc., 2008 FC 593; and Apotex Inc. v. Sanofi

Synthelabo Canada Inc., 2008 SCC 61

18 See The IP Year 2006 in Reviewhttp://www.fasken.com/publications/detail.aspx?publication=2694

.

19 See note 17.

20 See note 17.

21 See note 17.

22 2008 CAF 90.

23 See The IP Year 2007 in Review http://www.fasken.com/ip_the_year_2007_in_review/.

24 See The IP Year...